Skip to main content
. Author manuscript; available in PMC: 2022 Nov 17.
Published in final edited form as: Bone. 2020 Oct 20;142:115700. doi: 10.1016/j.bone.2020.115700

Table 2.

Incidence of any and all musculoskeletal morbidities among adults with and without SCI with one-year clean enrollment period.

Spinal Cord Injury No Outcome at Baseline
Case/Denominator Control/Denominator
Any Musculoskeletal 2518/3057 (82.4%)* 511657/1077396 (47.5%)
  Osteoarthritis 2659/6620 (40.2%)* 249195/1342834 (18.6%)
  Osteoporosis 1760/7338 (24.0%)* 88662/1421643 (6.2%)
  Pathologic fracture 1543/7648 (20.2%)* 20965/1469029 (1.4%)
  Disorders of muscle, joint, ligaments, tendons, and connective tissues 3375/4382 (77.0%)* 514011/1163784 (44.2%)
  Sarcopenia and weakness 2540/8177 (31.1%)* 90152/1456285 (6.2%)
  Myalgia 1310/8311 (15.8%)* 119512/1422838 (8.4%)
  Rheumatoid arthritis, myositis, and musculoskeletal infections 414/8724 (4.7%)* 29099/1455696 (2.0%)
*

P<.01 and standard mean difference (SMD) ≥0.2

Denominators for both cases and controls reflect a one-year clean period during their enrollment for the specific condition. For instance, among cases (SCI), there exist 6,620 patients whose first year of enrollment had no evidence of osteoarthritis; therefore, inferred incident osteoarthritis could be estimated for this subset of the full SCI cohort. As a result, all patient cohorts’ denominators dynamically change conditional on the incident outcome being measured to ensure a clean period in the first year of enrollment.